Can Islet Cell Antibodies Predict IDDM in the General Population?
The DOI matches its Crossref record.
Abstract
Objective— To evaluate the likely prognostic significance of ICAs in children with no family history of IDDM. Research Design and Methods— We examined the prevalence of ICAs in 2925 English schoolchildren aged 9–13 yr and in 274 age-matched siblings of children with diabetes from the same region, and we compared the estimated risk of progression to diabetes within 10 yr in the two groups. Results— ICAs were present at levels ≥ 4 JDF U in 2.8% of schoolchildren and 6.6% of siblings and at ≥ 20 JDF U in 0.8% of schoolchildren and 2.2% of siblings. Although ICAs are only 2–3 times more prevalent in siblings than schoolchildren, the estimated cumulative risk that siblings will progress to diabetes by age 21 is 13 times greater (2.8 vs. 0.21%). Conclusions— ICAs are unexpectedly prevalent in English schoolchildren, but only a small minority, with this evidence of immune activation directed against islet cells, will progress to diabetes. Although ICAs alone have limited predictive value in the general population, combining two or more predictive tests in series could achieve a level of prediction equivalent to that now obtained in first-degree relatives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Bingley, P. J., Christie, M. R., Bonifacio, E., Bonfanti, R., Shattock, M., Fonte, M.-T., Bottazzo, G.-F., & Gale, E. A. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1304 · Cited by 389
Self-citationBiochemical markers of type 1 diabetes: clinical use
Pozzilli, S. M. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655101753352031 · Cited by 311
A Novel Micro-assay for Insulin Autoantibodies
Williams, A. J. K., Bingley, P. J., Bonifacio, E., Palmer, J. P., & Gale, E. A. M. (1997) · Journal of Autoimmunity · doi:10.1006/jaut.1997.0154 · Cited by 238
Self-citationThe World Health Organization International Collaborative Study for islet cell antibodies
Mire-Sluis, A. R., Gaines Das, R., & Lernmark, Å. (2000) · Diabetologia · doi:10.1007/s001250051524 · Cited by 122
Advances in the Prediction and Natural History of Type 1 Diabetes
Bonifacio, E., & Ziegler, A. G. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.007 · Cited by 61
Self-citationTsirogianni, A., Pipi, E., & Soufleros, K. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.02.019 · Cited by 56
Risk assessment, prediction and prevention of type 1 diabetes
Harrison, L. C. (2001) · Pediatric Diabetes · doi:10.1034/j.1399-5448.2001.002002071.x · Cited by 48
“The lower prevalence of diabetes in the general population compared with relatives means that the predictive value of islet antibodies for diabetes will also be lower in them, in accordance with Baye’s theorem; hence the prevalence of ICA and specific islet antibodies in the general population greatly exceeds that of…”
ResultMarčiulionytė, D., Williams, A. J. K., Bingley, P. J., Urbonaitė, B., & Gale, E. A. M. (2001) · Diabetologia · doi:10.1007/s001250051574 · Cited by 27
Self-citation
Metadata
- Authors
- Bingley, P. J., Bonifacio, E., Shattock, M., Gillmor, H. A., Sawtell, P. A., Dunger, D. B., Scott, R. D. M., Bottazzo, G. F., & Gale, E. A. M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1993-01-01
- Volume
- 16
- Issue
- 1
- Pages
- 45-50
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2025352965
- Cited by
- 89
- References
- 0
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.